Triamcinolone acetonide and Abnormal behavior - a phase IV clinical study of FDA data

Summary:

Abnormal behavior is reported as a side effect among people who take Triamcinolone acetonide (triamcinolone acetonide), especially for people who are female, 60+ old, also take Lyrica, and have Pain.

The phase IV clinical study analyzes which people have Abnormal behavior when taking Triamcinolone acetonide. It is created by eHealthMe based on reports of 19,460 people who have side effects when taking Triamcinolone acetonide from the FDA, and is updated regularly.

What is Triamcinolone acetonide?

Triamcinolone acetonide has active ingredients of triamcinolone acetonide. It is often used in eczema. eHealthMe is studying from 19,594 Triamcinolone acetonide users. Check the latest studies of Triamcinolone acetonide.

What is Abnormal behavior?

Abnormal behavior is found to be associated with 1,365 drugs and 1,948 conditions by eHealthMe. Check the latest studies of Abnormal behavior.

On Jul, 11, 2026

19,460 people reported to have side effects when taking Triamcinolone acetonide.
Among them, 26 people (0.13%) have Abnormal behavior.

Could Triamcinolone acetonide cause Abnormal behavior?

Among these 26 people:

What is the gender of people who have Abnormal behavior when taking Triamcinolone acetonide? *

female: 57.69 %
male: 42.31 %

What is the age of people who have Abnormal behavior when taking Triamcinolone acetonide? *

What are other drugs people take besides Triamcinolone acetonide? *

What are other side effects people have besides Abnormal behavior? *

Memory Loss: 9 people, 34.62%
Aggression: 8 people, 30.77%
Gait Disturbance: 7 people, 26.92%
Sleep Walking (walking during sleep): 7 people, 26.92%
Disturbance In Attention: 7 people, 26.92%
Hallucinations (sensations that appear real but are created by your mind): 6 people, 23.08%
Dyspnea (difficult or laboured breathing): 6 people, 23.08%
Insomnia (sleeplessness): 6 people, 23.08%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 6 people, 23.08%
Psychotic Disorder: 6 people, 23.08%

What are the existing conditions these people have? *

Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 38.46%
Pain: 10 people, 38.46%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 6 people, 23.08%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 23.08%
Drowsiness: 5 people, 19.23%
Neuropathy Peripheral (surface nerve damage): 4 people, 15.38%
Wheezing (a high-pitched whistling sound made while you breath): 3 people, 11.54%
Dyspnea (difficult or laboured breathing): 3 people, 11.54%
Weight Decreased: 2 people, 7.69%
Itching: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Triamcinolone acetonide and have Abnormal behavior?

- Check whether Abnormal behavior is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Triamcinolone acetonide:

Triamcinolone acetonide (19,594 reports)

Browse all side effects of Triamcinolone acetonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abnormal behavior:

Abnormal behavior (1,365 drugs)

Browse all the conditions that are associated with Abnormal behavior:

Abnormal behavior (1,948 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Triamcinolone acetonide) and Triamcinolone acetonide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.